- Home
- FTS vs LH Comparison
FTS vs LH Comparison
Compare FTS & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FTS | LH |
|---|---|---|
| Founded | 1885 | 1971 |
| Country | Canada | United States |
| Employees | N/A | 70000 |
| Industry | Electric Utilities: Central | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.5B | 25.9B |
| IPO Year | 2016 | 2005 |
Fundamental Metrics
Financial Performance| Metric | FTS | LH |
|---|---|---|
| Price | $54.09 | $320.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $67.00 | ★ $311.33 |
| AVG Volume (30 Days) | 608.8K | ★ 656.0K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.22% | 1.12% |
| EPS Growth | N/A | ★ 18.33 |
| EPS | N/A | ★ 6.99 |
| Revenue | N/A | ★ $13,951,700,000.00 |
| Revenue This Year | $11.05 | $8.26 |
| Revenue Next Year | $5.32 | $4.81 |
| P/E Ratio | ★ $22.72 | $46.17 |
| Revenue Growth | N/A | ★ 7.25 |
| 52 Week Low | $48.90 | $244.52 |
| 52 Week High | $59.40 | $341.80 |
Technical Indicators
Market Signals| Indicator | FTS | LH |
|---|---|---|
| Relative Strength Index (RSI) | 39.07 | 49.83 |
| Support Level | $50.45 | $250.82 |
| Resistance Level | $57.69 | $341.80 |
| Average True Range (ATR) | 0.73 | 8.06 |
| MACD | -0.04 | -1.68 |
| Stochastic Oscillator | 27.51 | 49.52 |
Price Performance
Historical ComparisonAbout FTS Fortis Inc.
Fortis owns and operates eight utility transmission and distribution subsidiaries in Canada and the United States, serving 3.5 million electricity and gas customers. The company has smaller stakes in electricity generation and several Caribbean utilities. Subsidiary ITC operates electric transmission in seven US states, with more than 16,000 miles of high-voltage transmission lines in operation.
About LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.